Achilles Therapeutics plc

ACHL · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$131,539$173,338$266,319$177,849
Short-Term Investments$0$0$0$0
Receivables$10,351$16,003$11,173$7,339
Inventory$0$4,624$5,133$0
Other Curr. Assets$3,743$2,615$2,124$2,609
Total Curr. Assets$145,633$196,580$284,749$187,797
Property Plant & Equip (Net)$13,543$20,480$28,791$28,109
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$33$33$33$0
Tax Assets$41$251$26$4
Other NC Assets$2,206$3,047$3,540$3,008
Total NC Assets$15,823$23,778$32,357$31,121
Other Assets$0$0$0$0
Total Assets$161,456$220,358$317,106$218,918
Liabilities
Payables$5,629$5,187$3,722$6,314
Short-Term Debt$3,539$4,188$4,482$3,712
Tax Payable$0$326$0$7
Deferred Revenue$0$0$9,638$5,227
Other Curr. Liab.$7,828$8,292$10,906$6,590
Total Curr. Liab.$16,996$17,993$19,110$16,623
LT Debt$1,076$4,388$7,777$12,271
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,015$933$691$652
Total NC Liab.$2,091$5,321$8,468$12,923
Other Liabilities$0$0$0$0
Cap. Leases$4,615$8,576$12,259$15,983
Total Liabilities$19,087$23,314$27,578$29,546
Equity
Pref Stock$0$0$0$134
Common Stock$182$54$54$25
Retained Earnings-$259,952-$190,287-$119,111-$58,012
AOCI-$13,071-$21,695$6,636$12,322
Other Equity$415,210$408,972$401,949$234,922
Total Equity$142,369$197,044$289,528$189,372
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$161,456$220,358$317,106$218,918
Net Debt-$126,924-$164,762-$254,060-$161,866